Ellis Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-423
| Closed | -$26K | – | 404 |
|
2022
Q3 | $26K | Buy |
423
+4
| +1% | +$246 | 0.01% | 457 |
|
2022
Q2 | $25K | Sell |
419
-195
| -32% | -$11.6K | 0.01% | 475 |
|
2022
Q1 | $36K | Buy |
614
+108
| +21% | +$6.33K | 0.01% | 452 |
|
2021
Q4 | $36K | Buy |
506
+123
| +32% | +$8.75K | 0.01% | 462 |
|
2021
Q3 | $26K | Buy |
383
+3
| +0.8% | +$204 | 0.01% | 477 |
|
2021
Q2 | $26K | Buy |
380
+4
| +1% | +$274 | 0.01% | 479 |
|
2021
Q1 | $24K | Buy |
376
+4
| +1% | +$255 | 0.01% | 477 |
|
2020
Q4 | $22K | Sell |
372
-201
| -35% | -$11.9K | 0.01% | 467 |
|
2020
Q3 | $36K | Buy |
573
+6
| +1% | +$377 | 0.01% | 406 |
|
2020
Q2 | $43K | Sell |
567
-577
| -50% | -$43.8K | 0.02% | 378 |
|
2020
Q1 | $82K | Buy |
1,144
+52
| +5% | +$3.73K | 0.04% | 224 |
|
2019
Q4 | $71K | Sell |
1,092
-577
| -35% | -$37.5K | 0.02% | 290 |
|
2019
Q3 | $105K | Buy |
1,669
+84
| +5% | +$5.29K | 0.04% | 221 |
|
2019
Q2 | $107K | Buy |
+1,585
| New | +$107K | 0.04% | 219 |
|